annual D&A:
$7.96M+$1.12M(+16.45%)Summary
- As of today (May 30, 2025), AXSM annual depreciation & amortization is $7.96 million, with the most recent change of +$1.12 million (+16.45%) on December 31, 2024.
- During the last 3 years, AXSM annual D&A has risen by +$7.88 million (+10371.05%).
- AXSM annual D&A is now at all-time high.
Performance
AXSM Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$2.13M+$60.00K(+2.89%)Summary
- As of today (May 30, 2025), AXSM quarterly depreciation & amortization is $2.13 million, with the most recent change of +$60.00 thousand (+2.89%) on March 31, 2025.
- Over the past year, AXSM quarterly D&A has increased by +$302.00 thousand (+16.49%).
- AXSM quarterly D&A is now at all-time high.
Performance
AXSM quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$8.26M+$302.00K(+3.79%)Summary
- As of today (May 30, 2025), AXSM TTM depreciation & amortization is $8.26 million, with the most recent change of +$302.00 thousand (+3.79%) on March 31, 2025.
- Over the past year, AXSM TTM D&A has increased by +$1.26 million (+17.95%).
- AXSM TTM D&A is now at all-time high.
Performance
AXSM TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AXSM Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.4% | +16.5% | +17.9% |
| 3 y3 years | +10000.0% | +583.6% | +6971.9% |
| 5 y5 years | +10000.0% | +10000.0% | +10000.0% |
AXSM Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | at high | +583.6% | at high | +6971.9% |
| 5 y | 5-year | at high | >+9999.0% | at high | +376.2% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | at high | +376.2% | at high | >+9999.0% |
AXSM Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $2.13M(+2.9%) | $8.26M(+3.8%) |
| Dec 2024 | $7.96M(+16.4%) | $2.07M(+0.6%) | $7.96M(+4.4%) |
| Sep 2024 | - | $2.06M(+3.4%) | $7.63M(+4.4%) |
| Jun 2024 | - | $1.99M(+8.8%) | $7.31M(+4.3%) |
| Mar 2024 | - | $1.83M(+5.2%) | $7.00M(+2.5%) |
| Dec 2023 | $6.83M(+55.2%) | $1.74M(-0.2%) | $6.83M(+0.7%) |
| Sep 2023 | - | $1.74M(+3.2%) | $6.79M(+0.9%) |
| Jun 2023 | - | $1.69M(+1.6%) | $6.72M(+16.9%) |
| Mar 2023 | - | $1.66M(-1.8%) | $5.75M(+30.7%) |
| Dec 2022 | $4.40M(+5692.1%) | $1.69M(+0.7%) | $4.40M(+127.2%) |
| Sep 2022 | - | $1.68M(+134.0%) | $1.94M(+247.6%) |
| Jun 2022 | - | $718.00K(+130.1%) | $557.40K(+377.2%) |
| Mar 2022 | - | $312.00K(-140.4%) | $116.80K(+53.9%) |
| Dec 2021 | $76.00K(-2.2%) | -$772.30K(-357.7%) | $75.90K(-91.7%) |
| Sep 2021 | - | $299.70K(+8.0%) | $909.40K(+47.8%) |
| Jun 2021 | - | $277.40K(+2.3%) | $615.20K(+79.2%) |
| Mar 2021 | - | $271.10K(+343.0%) | $343.30K(+342.4%) |
| Dec 2020 | $77.70K | $61.20K(+1012.7%) | $77.60K(+256.0%) |
| Sep 2020 | - | $5500.00(0.0%) | $21.80K(-15.2%) |
| Jun 2020 | - | $5500.00(+1.9%) | $25.70K(-17.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $5400.00(0.0%) | $31.30K(-16.1%) |
| Dec 2019 | $37.30K(-23.7%) | $5400.00(-42.6%) | $37.30K(-15.4%) |
| Sep 2019 | - | $9400.00(-15.3%) | $44.10K(-7.7%) |
| Jun 2019 | - | $11.10K(-2.6%) | $47.80K(-1.2%) |
| Mar 2019 | - | $11.40K(-6.6%) | $48.40K(-1.0%) |
| Dec 2018 | $48.90K(+14.8%) | $12.20K(-6.9%) | $48.90K(+1.9%) |
| Sep 2018 | - | $13.10K(+12.0%) | $48.00K(+5.0%) |
| Jun 2018 | - | $11.70K(-1.7%) | $45.70K(+2.9%) |
| Mar 2018 | - | $11.90K(+5.3%) | $44.40K(+4.2%) |
| Dec 2017 | $42.60K(+107.8%) | $11.30K(+4.6%) | $42.60K(+3.6%) |
| Sep 2017 | - | $10.80K(+3.8%) | $41.10K(+14.5%) |
| Jun 2017 | - | $10.40K(+3.0%) | $35.90K(+26.0%) |
| Mar 2017 | - | $10.10K(+3.1%) | $28.50K(+39.0%) |
| Dec 2016 | $20.50K(+485.7%) | $9800.00(+75.0%) | $20.50K(+70.8%) |
| Sep 2016 | - | $5600.00(+86.7%) | $12.00K(+60.0%) |
| Jun 2016 | - | $3000.00(+42.9%) | $7500.00(+38.9%) |
| Mar 2016 | - | $2100.00(+61.5%) | $5400.00(+50.0%) |
| Dec 2015 | $3500.00 | $1300.00(+18.2%) | $3600.00(+56.5%) |
| Sep 2015 | - | $1100.00(+22.2%) | $2300.00(+91.7%) |
| Jun 2015 | - | $900.00(+200.0%) | $1200.00(+300.0%) |
| Mar 2015 | - | $300.00 | $300.00 |
FAQ
- What is Axsome Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Axsome Therapeutics?
- What is Axsome Therapeutics annual D&A year-on-year change?
- What is Axsome Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly D&A year-on-year change?
- What is Axsome Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Axsome Therapeutics?
- What is Axsome Therapeutics TTM D&A year-on-year change?
What is Axsome Therapeutics annual depreciation & amortization?
The current annual D&A of AXSM is $7.96M
What is the all time high annual D&A for Axsome Therapeutics?
Axsome Therapeutics all-time high annual depreciation & amortization is $7.96M
What is Axsome Therapeutics annual D&A year-on-year change?
Over the past year, AXSM annual depreciation & amortization has changed by +$1.12M (+16.45%)
What is Axsome Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of AXSM is $2.13M
What is the all time high quarterly D&A for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly depreciation & amortization is $2.13M
What is Axsome Therapeutics quarterly D&A year-on-year change?
Over the past year, AXSM quarterly depreciation & amortization has changed by +$302.00K (+16.49%)
What is Axsome Therapeutics TTM depreciation & amortization?
The current TTM D&A of AXSM is $8.26M
What is the all time high TTM D&A for Axsome Therapeutics?
Axsome Therapeutics all-time high TTM depreciation & amortization is $8.26M
What is Axsome Therapeutics TTM D&A year-on-year change?
Over the past year, AXSM TTM depreciation & amortization has changed by +$1.26M (+17.95%)